MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin

Yongfeng Zhang, Xueqin Wang, Yuehua ZhaoMolecular 2018 · DOI · OpenAlex

Abstract MicroRNAs (miRNAs/miRs) serve important roles in regulating gene expression by directly binding to the 3'‑untranslated regions of target genes. Multiple miRNAs are dysregulated in retinoblastoma (RB) and their dysregulation is closely related to RB malignancy. Therefore, exploring the detailed roles of miRNAs in RB is valuable to facilitate the development of effective therapeutic targets for patients with this disease. miRNA‑874‑3p (miR‑874) has been recently reported to be downregulated in several types of human cancer and serves an essential role in cancer progression. However, the expression pattern and detailed roles of miR‑874 in RB, as well as the underlying molecular mechanisms in RB, have not been clearly elucidated. Therefore, this study detected miR‑874 expression in RB tissues and cell lines. The biological roles of miR‑874 in RB were determined and the underlying mechanisms of its actions in RB cells were also examined. This study revealed that miR‑874 expression was aberrantly underexpressed in RB tissues and cell lines. However, returning miR‑874 expression restricted the proliferative and invasive abilities of RB cells. In terms of the underlying mechanism, metadherin (MTDH) was validated as a direct target gene of miR‑874 in RB cells. MTDH inhibition could imitate the inhibitory roles of miR‑874 overexpression in RB cells. Furthermore, forced MTDH expression partially reversed the suppressive effects of miR‑874 on RB cells. In conclusion, this study revealed that miR‑874 may inhibit RB progression by directly targeting MTDH. Restoration of miR‑874 expression may be a novel strategy for preventing the rapid growth and metastasis of RB cells.

Note: This paper has been retracted by the journal Molecular Medicine Reports. The following summary is based on the original text and should be treated with caution.

Introduction

Retinoblastoma (RB) is a rare pediatric eye cancer that can lead to severe outcomes if it metastasizes. Research into microRNAs (miRNAs) has revealed their role as key regulators in cancer progression. miR-874, in particular, has been noted for its tumor-suppressive properties in various malignancies. This study investigated the expression and functional impact of miR-874 in retinoblastoma to identify potential therapeutic targets.

Methods

The study compared miR-874 expression in 26 human RB tissues against 8 normal retinal tissues using RT-qPCR. Similar comparisons were made between RB cell lines (SO-RB50, Y79, Weri-RB1) and a normal control line (ARPE-19). Functional consequences of miR-874 restoration were evaluated through MTT proliferation assays and Transwell invasion assays. The study also employed bioinformatics and luciferase reporter assays to identify and validate metadherin (MTDH) as a direct target of miR-874.

Results

The primary finding was a significant downregulation of miR-874 in RB tissues and cell lines compared to normal controls.

Expression of miR-874 is significantly reduced in retinoblastoma (RB) tissues (A) and cell lines (B) compared to normal controls.

Restoring miR-874 expression significantly inhibited the proliferation and invasion of RB cells. Mechanistically, miR-874 was shown to directly target the 3'-UTR of MTDH. Rescue experiments demonstrated that overexpressing MTDH could partially counteract the tumor-suppressive effects of miR-874, confirming MTDH as a functional downstream target.

Discussion

The study concludes that miR-874 acts as a tumor suppressor in retinoblastoma by negatively regulating MTDH. This suggests that therapeutic strategies aimed at restoring miR-874 levels could potentially inhibit RB growth and metastasis. However, the authors note the need for in vivo validation and a better understanding of the broader miRNA-target network.

Disclaimer: Due to the retraction of the original article, the data integrity and conclusions presented here are not verified. Readers should refer to the official retraction notice for more information.

Summary updated

Abstract

MicroRNAs (miRNAs/miRs) serve important roles in regulating gene expression by directly binding to the 3'‑untranslated regions of target genes. Multiple miRNAs are dysregulated in retinoblastoma (RB) and their dysregulation is closely related to RB malignancy. Therefore, exploring the detailed roles of miRNAs in RB is valuable to facilitate the development of effective therapeutic targets for patients with this disease. miRNA‑874‑3p (miR‑874) has been recently reported to be downregulated in several types of human cancer and serves an essential role in cancer progression. However, the expression pattern and detailed roles of miR‑874 in RB, as well as the underlying molecular mechanisms in RB, have not been clearly elucidated. Therefore, this study detected miR‑874 expression in RB tissues and cell lines. The biological roles of miR‑874 in RB were determined and the underlying mechanisms of its actions in RB cells were also examined. This study revealed that miR‑874 expression was aberrantly underexpressed in RB tissues and cell lines. However, returning miR‑874 expression restricted the proliferative and invasive abilities of RB cells. In terms of the underlying mechanism, metadherin (MTDH) was validated as a direct target gene of miR‑874 in RB cells. MTDH inhibition could imitate the inhibitory roles of miR‑874 overexpression in RB cells. Furthermore, forced MTDH expression partially reversed the suppressive effects of miR‑874 on RB cells. In conclusion, this study revealed that miR‑874 may inhibit RB progression by directly targeting MTDH. Restoration of miR‑874 expression may be a novel strategy for preventing the rapid growth and metastasis of RB cells.
BibTeX
@inproceedings{zhang2018microrna,
  author = {Yongfeng Zhang and Xueqin Wang and Yuehua Zhao},
  title = {{MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin}},
  booktitle = {Molecular},
  year = {2018},
  doi = {10.3892/mmr.2018.9295},
}
Figure